Lucid Diagnostics (LUCD)
(Delayed Data from NSDQ)
$1.07 USD
0.00 (0.00%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $1.08 +0.01 (0.93%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Lucid Diagnostics Inc. has a market cap of $116.07M, which represents its share price of $1.07 multiplied by its outstanding shares number of 108.48M. As a small-cap company, LUCD's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LUCD 1.07 0.00(0.00%)
Will LUCD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LUCD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LUCD
Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Tops Revenue Estimates
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates
LUCD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inogen (INGN) Reports Q2 Loss, Beats Revenue Estimates
Mesa Labs (MLAB) Lags Q1 Earnings and Revenue Estimates
Hologic (HOLX) Q3 Earnings and Revenues Beat Estimates
Other News for LUCD
Is LUCD preparing to trend lower? Non-ADX 1,2,3,4 Bearish shows up after a flat session
LUCD forms New Uptrend on September 16
NR7 appears for LUCD after 2.91% move
180 Bearish Setup appears for LUCD after 3.74% move
LUCD forms Calm After Storm on September 11